192 related articles for article (PubMed ID: 22792160)
1. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.
Eisenhardt M; Glässner A; Krämer B; Körner C; Sibbing B; Kokordelis P; Nischalke HD; Sauerbruch T; Spengler U; Nattermann J
PLoS One; 2012; 7(7):e38846. PubMed ID: 22792160
[TBL] [Abstract][Full Text] [Related]
2. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
3. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
4. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
5. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
[TBL] [Abstract][Full Text] [Related]
7. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
8. Highly activated TRAIL
Jiang Y; Qin S; Wei X; Liu X; Guan J; Zhu H; Chang G; Chen Y; Lu H; Qian J; Wang Z; Shen M; Lin X
Immunol Lett; 2021 Apr; 232():9-19. PubMed ID: 33515618
[TBL] [Abstract][Full Text] [Related]
9. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.
Glässner A; Eisenhardt M; Krämer B; Körner C; Coenen M; Sauerbruch T; Spengler U; Nattermann J
Lab Invest; 2012 Jul; 92(7):967-77. PubMed ID: 22449797
[TBL] [Abstract][Full Text] [Related]
10. Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.
Cosgrove C; Berger CT; Kroy DC; Cheney PC; Ghebremichael M; Aneja J; Tomlinson M; Kim AY; Lauer GM; Alter G
PLoS One; 2014; 9(8):e105950. PubMed ID: 25148254
[TBL] [Abstract][Full Text] [Related]
11. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
12. Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4
Polo ML; Ghiglione YA; Salido JP; Urioste A; Poblete G; Sisto AE; Martinez A; Rolón MJ; Ojeda DS; Cahn PE; Turk GJ; Laufer NL
J Int AIDS Soc; 2019 Sep; 22(9):e25375. PubMed ID: 31536177
[TBL] [Abstract][Full Text] [Related]
13. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.
Shi J; Zhao J; Zhang X; Cheng Y; Hu J; Li Y; Zhao X; Shang Q; Sun Y; Tu B; Shi L; Gao B; Wang FS; Zhang Z
Sci Rep; 2017 Mar; 7():44544. PubMed ID: 28291251
[TBL] [Abstract][Full Text] [Related]
14. Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection.
Golden-Mason L; Hahn YS; Strong M; Cheng L; Rosen HR
PLoS One; 2014; 9(7):e103219. PubMed ID: 25076408
[TBL] [Abstract][Full Text] [Related]
15. Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type.
Langhans B; Alwan AW; Krämer B; Glässner A; Lutz P; Strassburg CP; Nattermann J; Spengler U
J Hepatol; 2015 Feb; 62(2):398-404. PubMed ID: 25195554
[TBL] [Abstract][Full Text] [Related]
16. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population.
Marquardt N; Wilk E; Pokoyski C; Schmidt RE; Jacobs R
Eur J Immunol; 2010 May; 40(5):1428-39. PubMed ID: 20186880
[TBL] [Abstract][Full Text] [Related]
17. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
[TBL] [Abstract][Full Text] [Related]
18. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
19. IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells.
Preisser L; Miot C; Le Guillou-Guillemette H; Beaumont E; Foucher ED; Garo E; Blanchard S; Frémaux I; Croué A; Fouchard I; Lunel-Fabiani F; Boursier J; Roingeard P; Calès P; Delneste Y; Jeannin P
Hepatology; 2014 Dec; 60(6):1879-90. PubMed ID: 25066464
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.
Morandi F; Ferretti E; Castriconi R; Dondero A; Petretto A; Bottino C; Pistoia V
Blood; 2011 Nov; 118(22):5840-50. PubMed ID: 21989990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
